These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9927694)

  • 1. Gene therapy to promote thromboresistance: local overexpression of tissue plasminogen activator to prevent arterial thrombosis in an in vivo rabbit model.
    Waugh JM; Kattash M; Li J; Yuksel E; Kuo MD; Lussier M; Weinfeld AB; Saxena R; Rabinovsky ED; Thung S; Woo SL; Shenaq SM
    Proc Natl Acad Sci U S A; 1999 Feb; 96(3):1065-70. PubMed ID: 9927694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local overexpression of thrombomodulin for in vivo prevention of arterial thrombosis in a rabbit model.
    Waugh JM; Yuksel E; Li J; Kuo MD; Kattash M; Saxena R; Geske R; Thung SN; Shenaq SM; Woo SL
    Circ Res; 1999 Jan 8-22; 84(1):84-92. PubMed ID: 9915777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of neointima formation with tissue-type plasminogen activator.
    Hilfiker PR; Waugh JM; Li-Hawkins JJ; Kuo MD; Yuksel E; Geske RS; Cifra PN; Chawla M; Weinfeld AB; Thomas JW; Shenaq SM; Dake MD
    J Vasc Surg; 2001 Apr; 33(4):821-8. PubMed ID: 11296338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seeding of vascular grafts with genetically modified endothelial cells. Secretion of recombinant TPA results in decreased seeded cell retention in vitro and in vivo.
    Dunn PF; Newman KD; Jones M; Yamada I; Shayani V; Virmani R; Dichek DA
    Circulation; 1996 Apr; 93(7):1439-46. PubMed ID: 8641034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retroviral gene transfer of tissue-type plasminogen activator targets thrombolysis in vitro and in vivo.
    Gong YS; Zhang KL; Jiang XG; Wang ZW; Sun ZQ; Cai J
    Gene Ther; 2007 Nov; 14(21):1537-42. PubMed ID: 17728795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenoviral-mediated transfer of tissue plasminogen activator gene into brain capillary endothelial cells in vitro.
    Kim JA; Hedrick CC; Xie D; Fisher MJ
    Angiology; 2001 Sep; 52(9):627-34. PubMed ID: 11570662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of a mutant tissue-type plasminogen activator, YM866, with a tissue-type plasminogen activator in a canine model of femoral arterial thrombosis.
    Kawasaki T; Kaku S; Sakai Y; Takenaka T
    J Pharm Pharmacol; 1996 Oct; 48(10):1041-8. PubMed ID: 8953506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of locally applied tissue-type plasminogen activator on venous fibrinolytic activity: in vitro and in vivo investigations.
    Underwood MJ; More RS; Gershlick AH; de Bono DP
    Cardiovasc Res; 1993 Dec; 27(12):2270-3. PubMed ID: 8313438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low dose tissue plasminogen activator treatment for vascular thrombosis following cardiac catheterization in children: a single center experience.
    Bratincsák A; Moore JW; El-Said HG
    Catheter Cardiovasc Interv; 2013 Nov; 82(5):782-5. PubMed ID: 22718305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of selective endoperoxide/thromboxane A2 receptor antagonism with sulotroban on tPA-induced thrombolysis in a rabbit model of femoral arterial thrombosis.
    Fujita T; Hasan S; Storer BL; Shebuski RJ
    Fundam Clin Pharmacol; 1989; 3(6):643-53. PubMed ID: 2533138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrovirus-Mediated Transfection of the Tissue-type Plasminogen Activator Gene Results in Increased Thrombolysis of Blood Clots.
    Wu X; Gong Y; Ding X; Cheng G; Yan W; She X; Wang C; Li X
    Biochem Genet; 2019 Apr; 57(2):234-247. PubMed ID: 30218285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of thromboxane synthase inhibition on the thrombolytic action of tissue-type plasminogen activator in a rabbit model of peripheral arterial thrombosis.
    Shebuski RJ; Storer BL; Fujita T
    Thromb Res; 1988 Dec; 52(5):381-92. PubMed ID: 3146820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative time course of thrombolysis induced by intravenous boluses and infusion of staphylokinase and tissue plasminogen activator in a rabbit arterial thrombosis model.
    Helft G; Bara L; Bloch MF; Samama MM
    Blood Coagul Fibrinolysis; 1998 Jul; 9(5):411-7. PubMed ID: 9712289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue-type plasminogen activator gene targets thrombolysis in atriums.
    Gong Y; Wang F; Li X; Gao Z; Zhang K; Fan C; Liu X
    J Thromb Thrombolysis; 2010 Nov; 30(4):507-14. PubMed ID: 20924774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Shear Stress and tPA Concentration in the Fibrinolytic Potential of Thrombi.
    Whyte CS; Mostefai HA; Baeten KM; Lucking AJ; Newby DE; Booth NA; Mutch NJ
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-level expression of recombinant human tPA in cultivated canine endothelial cells under varying conditions of retroviral gene transfer.
    Podrazik RM; Whitehill TA; Ekhterae D; Williams WD; Messina LM; Stanley JC
    Ann Surg; 1992 Oct; 216(4):446-52; discussion 453. PubMed ID: 1417194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local gene delivery: arterial thrombosis model for endothelial cell-targeted thrombolytic gene therapy research.
    Shenaq SM; Kattash MM; Weinfeld AB; Waugh JM; Yüksel E; Yüksel M; Gura DH
    J Reconstr Microsurg; 1999 Jan; 15(1):73-9. PubMed ID: 10025534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced in vivo antithrombotic effects of endothelial cells expressing recombinant plasminogen activators transduced with retroviral vectors.
    Dichek DA; Anderson J; Kelly AB; Hanson SR; Harker LA
    Circulation; 1996 Jan; 93(2):301-9. PubMed ID: 8548903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus-mediated transfer of tissue-type plasminogen activator augments thrombolysis in tissue-type plasminogen activator-deficient and plasminogen activator inhibitor-1-overexpressing mice.
    Carmeliet P; Stassen JM; Van Vlaenderen I; Meidell RS; Collen D; Gerard RD
    Blood; 1997 Aug; 90(4):1527-34. PubMed ID: 9269770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1998 ARRS President's Award. The potential of in vivo vascular tissue engineering for the treatment of vascular thrombosis: a preliminary report. American Roentgen Ray Society.
    Kuo MD; Waugh JM; Yuksel E; Weinfeld AB; Yuksel M; Dake MD
    AJR Am J Roentgenol; 1998 Sep; 171(3):553-8. PubMed ID: 9725272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.